A Study to Evaluate Safety of ASC40 Tablets in Patients With Moderate to Severe Acne Vulgaris

NCT06248008 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne

Interventions

DRUG: ASC40

Sponsor

Ascletis Pharmaceuticals Co., Ltd.